ID

18026

Description

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00168727

Link

https://clinicaltrials.gov/show/NCT00168727

Keywords

Versions (1)
  1. 10/15/16 10/15/16 -
Uploaded on

October 15, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma, Non-Hodgkin NCT00168727

English

Eligibility Lymphoma, Non-Hodgkin NCT00168727

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
follicular non-hodgkin’s lymphoma including sll in first or second relapse.
Description

Lymphoma, Follicular | Small Lymphocytic Lymphoma First Relapse | Small Lymphocytic Lymphoma Relapse second

Data type

boolean

Alias
UMLS CUI [1]
C0024301
UMLS CUI [2,1]
C0855095
UMLS CUI [2,2]
C4054953
UMLS CUI [3,1]
C0855095
UMLS CUI [3,2]
C0035020
UMLS CUI [3,3]
C0205436
no anticancer therapy for three wks (six wks if nitrosourea or mitomycin c); not rituximab refractory.
Description

cancer treatment | Nitrosourea | Mitomycin | rituximab refractory

Data type

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C0028210
UMLS CUI [3]
C0002475
UMLS CUI [4,1]
C0393022
UMLS CUI [4,2]
C0205269
age >= 18 years, not pregnant or lactating.
Description

Age | Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
expected survival >= 3 mths; ps 0, 1, or 2.
Description

Continuance of life Expected | performance status

Data type

boolean

Alias
UMLS CUI [1,1]
C0038952
UMLS CUI [1,2]
C1517001
UMLS CUI [2]
C1518965
anc >= 1,500/mm3, platelet counts >= 100,000/mm3.
Description

Absolute neutrophil count | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
total bilirubin > 2.0 mg/dl, creatinine > 2.0 mg/dl.
Description

Serum total bilirubin measurement | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201976
total lymphocyte count < 5,000/mm3 for sll.
Description

Lymphocyte Count measurement Small Lymphocytic Lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0200635
UMLS CUI [1,2]
C0855095
<25% bone marrow involvement with lymphoma.
Description

Bone Marrow Percentage Involvement with Lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C1314939
UMLS CUI [1,4]
C0024299
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior abmt or asct, hypocellular or marked reduction in bone marrow precursors, or history of failed stem cell collection.
Description

Autologous bone marrow transplant | Transplantation of autologous hematopoietic stem cell | Bone marrow depression | Stem Cell Isolation failed

Data type

boolean

Alias
UMLS CUI [1]
C0194037
UMLS CUI [2]
C1831743
UMLS CUI [3]
C0151773
UMLS CUI [4,1]
C3827940
UMLS CUI [4,2]
C0231175
bulky areas of disease more than 10 cm in diameter.
Description

Bulky Disease Area Diameter

Data type

boolean

Alias
UMLS CUI [1,1]
C1511341
UMLS CUI [1,2]
C0205146
UMLS CUI [1,3]
C1301886
patients with cll, cns, or mantle cell lymphoma.
Description

Chronic Lymphocytic Leukemia | Central nervous system lymphoma | Mantle cell lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0023434
UMLS CUI [2]
C0742472
UMLS CUI [3]
C0334634
hx of hiv/aids related lymphoma, hepatitis b or c.
Description

Lymphoma, AIDS-Related | Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0085090
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
prior radioimmunotherapy or xrt to >25% of active bone marrow.
Description

Radioimmunotherapy | X-ray beam therapy Bone Marrow Percentage

Data type

boolean

Alias
UMLS CUI [1]
C0085101
UMLS CUI [2,1]
C0436209
UMLS CUI [2,2]
C0005953
UMLS CUI [2,3]
C0439165
g-csf or gm-csf within 2 wks, pegylated g-csf within 4 wks of treatment
Description

Granulocyte Colony-Stimulating Factor | Granulocyte-Macrophage Colony-Stimulating Factor | pegylated granulocyte colony-stimulating factor

Data type

boolean

Alias
UMLS CUI [1]
C0079459
UMLS CUI [2]
C0079460
UMLS CUI [3]
C1452552
Back to the top of the page

Similar models

Eligibility Lymphoma, Non-Hodgkin NCT00168727

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Lymphoma, Follicular | Small Lymphocytic Lymphoma First Relapse | Small Lymphocytic Lymphoma Relapse second
Item
follicular non-hodgkin’s lymphoma including sll in first or second relapse.
boolean
C0024301 (UMLS CUI [1])
C0855095 (UMLS CUI [2,1])
C4054953 (UMLS CUI [2,2])
C0855095 (UMLS CUI [3,1])
C0035020 (UMLS CUI [3,2])
C0205436 (UMLS CUI [3,3])
cancer treatment | Nitrosourea | Mitomycin | rituximab refractory
Item
no anticancer therapy for three wks (six wks if nitrosourea or mitomycin c); not rituximab refractory.
boolean
C0920425 (UMLS CUI [1])
C0028210 (UMLS CUI [2])
C0002475 (UMLS CUI [3])
C0393022 (UMLS CUI [4,1])
C0205269 (UMLS CUI [4,2])
Age | Pregnancy | Breast Feeding
Item
age >= 18 years, not pregnant or lactating.
boolean
C0001779 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Continuance of life Expected | performance status
Item
expected survival >= 3 mths; ps 0, 1, or 2.
boolean
C0038952 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
C1518965 (UMLS CUI [2])
Absolute neutrophil count | Platelet Count measurement
Item
anc >= 1,500/mm3, platelet counts >= 100,000/mm3.
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Serum total bilirubin measurement | Creatinine measurement, serum
Item
total bilirubin > 2.0 mg/dl, creatinine > 2.0 mg/dl.
boolean
C1278039 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Lymphocyte Count measurement Small Lymphocytic Lymphoma
Item
total lymphocyte count < 5,000/mm3 for sll.
boolean
C0200635 (UMLS CUI [1,1])
C0855095 (UMLS CUI [1,2])
Bone Marrow Percentage Involvement with Lymphoma
Item
<25% bone marrow involvement with lymphoma.
boolean
C0005953 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0024299 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
Autologous bone marrow transplant | Transplantation of autologous hematopoietic stem cell | Bone marrow depression | Stem Cell Isolation failed
Item
prior abmt or asct, hypocellular or marked reduction in bone marrow precursors, or history of failed stem cell collection.
boolean
C0194037 (UMLS CUI [1])
C1831743 (UMLS CUI [2])
C0151773 (UMLS CUI [3])
C3827940 (UMLS CUI [4,1])
C0231175 (UMLS CUI [4,2])
Bulky Disease Area Diameter
Item
bulky areas of disease more than 10 cm in diameter.
boolean
C1511341 (UMLS CUI [1,1])
C0205146 (UMLS CUI [1,2])
C1301886 (UMLS CUI [1,3])
Chronic Lymphocytic Leukemia | Central nervous system lymphoma | Mantle cell lymphoma
Item
patients with cll, cns, or mantle cell lymphoma.
boolean
C0023434 (UMLS CUI [1])
C0742472 (UMLS CUI [2])
C0334634 (UMLS CUI [3])
Lymphoma, AIDS-Related | Hepatitis B | Hepatitis C
Item
hx of hiv/aids related lymphoma, hepatitis b or c.
boolean
C0085090 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Radioimmunotherapy | X-ray beam therapy Bone Marrow Percentage
Item
prior radioimmunotherapy or xrt to >25% of active bone marrow.
boolean
C0085101 (UMLS CUI [1])
C0436209 (UMLS CUI [2,1])
C0005953 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Granulocyte Colony-Stimulating Factor | Granulocyte-Macrophage Colony-Stimulating Factor | pegylated granulocyte colony-stimulating factor
Item
g-csf or gm-csf within 2 wks, pegylated g-csf within 4 wks of treatment
boolean
C0079459 (UMLS CUI [1])
C0079460 (UMLS CUI [2])
C1452552 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial